ADELA
SERRANO GIMENO
INVEST DOCT UV JUNIOR
Publikationen (40) Publikationen von ADELA SERRANO GIMENO
2024
-
Atrial Fibrillation Prevalence Rates and Its Association with Cardiovascular–Kidney–Metabolic Factors: SIMETAP-AF Study
Medicina (Lithuania), Vol. 60, Núm. 8
-
Hyperuricaemia Prevalence Rates According to Their Physiochemical and Epidemiological Diagnostic Criteria and Their Associations with Cardio-Renal-Metabolic Factors: SIMETAP-HU Study
Journal of Clinical Medicine, Vol. 13, Núm. 16
2023
-
Elevated pulse pressure and cardiovascular risk associated in Spanish population attended in primary care: IBERICAN study
Frontiers in Cardiovascular Medicine, Vol. 10
-
Heart Failure Prevalence Rates and Its Association with Other Cardiovascular Diseases and Chronic Kidney Disease: SIMETAP-HF Study
Journal of Clinical Medicine, Vol. 12, Núm. 15
-
Prevalence Rates of Arterial Hypertension According to the Threshold Criteria of 140/90 or 130/80 mmHg and Associated Cardiometabolic and Renal Factors: SIMETAP-HTN Study
Medicina (Lithuania), Vol. 59, Núm. 10
2022
-
Case-fatality rates of SARS-CoV-2 infection according to Autonomous Communities during the second epidemic wave in Spain
Semergen, Vol. 48, Núm. 4, pp. 252-262
-
Evaluation of prophylaxis in primary prevention with acetylsalicylic acid in people with diabetes: A scoping review
Semergen, Vol. 48, Núm. 4, pp. 275-292
-
SEMERGEN positioning on approaching chronic heart failure in primary care
Semergen, Vol. 48, Núm. 2, pp. 106-123
-
The natriuretic peptides in the diagnosis of heart failure in primary care setting
Semergen, Vol. 48, Núm. 7
2021
-
Analysis of case fatality rate of SARS-CoV-2 infection in the Spanish Autonomous Communities between March and May 2020
PLoS ONE, Vol. 16, Núm. 12 December 2021
-
Application of the PCR number of cycle threshold value (Ct) in COVID-19
Semergen, Vol. 47, Núm. 5, pp. 337-341
-
COVID-19 vaccine and anticoagulation patients at high cardiovascular risk. SEMERGEN recommendations
Semergen
-
GSE4-loaded nanoparticles a potential therapy for lung fibrosis that enhances pneumocyte growth, reduces apoptosis and DNA damage
FASEB Journal, Vol. 35, Núm. 3
2020
-
COVID-19. History repeats itself and we keep stumbling on the same stone
Semergen, Vol. 46, pp. 48-54
2017
-
Consensus on the Statin of Choice in Patients with Impaired Glucose Metabolism: Results of the DIANA Study
American Journal of Cardiovascular Drugs, Vol. 17, Núm. 2, pp. 135-142
-
Enfermedad renal crónica y dislipidemia
Clinica e Investigacion en Arteriosclerosis
2016
-
Consenso Delphi sobre el manejo de la dislipidemia en pacientes con alteración del metabolismo de la glucosa: Estudio Diana
Clinica e Investigacion en Arteriosclerosis, Vol. 28, Núm. 3, pp. 132-140
-
Delphi consensus on the diagnosis and management of dyslipidaemia in chronic kidney disease patients: A post hoc analysis of the DIANA study
Nefrologia, Vol. 36, Núm. 6, pp. 679-686
-
Evaluation of the Ocular Tolerance of Three Tacrolimus Topical Pharmaceutical Preparations by Bovine Corneal Opacity and Permeability Test
Current Eye Research, Vol. 41, Núm. 7, pp. 890-896
2015
-
Dietary inflammatory index and incidence of cardiovascular disease in the PREDIMED study
Nutrients, Vol. 7, Núm. 6, pp. 4124-4138